TRVI Earnings Date: Nov 12, 2026 (Estimated) — Trevi Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is TRVI's next earnings date?
Trevi Therapeutics, Inc. (TRVI) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.13.
How did TRVI do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Trevi Therapeutics, Inc. posted EPS of -$0.11 versus the -$0.11 estimate, a miss of 0.0%. Revenue was $0. The stock's 1-day post-earnings move was +0.1%.
How much does TRVI stock move after earnings?
TRVI beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.5% (up or down) in the day after earnings.
About Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the advancement and commercialization of Haduvio, a potential treatment for debilitating neurologically mediated conditions. This orally administered, extended-release formulation of nalbuphine is currently undergoing Phase IIb/III clinical trials for chronic pruritus (severe itching) and persistent cough experienced by patients with idiopathic pulmonary fibrosis. Trevi Therapeutics also possesses a licensing agreement with Endo Pharmaceuticals Inc., granting it the rights to develop and market products containing nalbuphine hydrochloride in various formulations. Established in 2011, the company maintains its corporate headquarters in New Haven, Connecticut.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.11 | -0.11 | +0.00% | $0 | ❌ Miss | +0.05% | -1.89% | -6.70% |
| 2026-05-05 | Q1 2026 | -0.07 | -0.09 | -28.57% | $0 | ❌ Miss | -2.73% | +0.68% | -4.98% |
| 2026-03-17 | Q4 2025 | -0.10 | -0.06 | +40.00% | $0 | ✅ Beat | -4.47% | -4.92% | +29.94% |
| 2025-11-13 | Q3 2025 | -0.10 | -0.08 | +20.00% | $0 | ✅ Beat | -0.79% | -7.07% | +10.03% |
| 2025-08-07 | Q2 2025 | -0.10 | -0.09 | +10.00% | $0 | ✅ Beat | +1.64% | +2.60% | +4.11% |
| 2025-05-08 | Q1 2025 | -0.12 | -0.09 | +25.00% | $0 | ✅ Beat | +0.00% | -6.21% | -2.88% |
| 2025-03-18 | Q4 2024 | -0.12 | -0.11 | +8.33% | $0 | ✅ Beat | +3.81% | +0.76% | -7.01% |
| 2024-11-06 | Q3 2024 | -0.12 | -0.13 | -8.33% | $0 | ❌ Miss | -6.45% | -7.74% | -10.97% |
Showing last 8 quarters.